The average 68Ga-PSMA PET/CT uptake in prostate cancer tumours and in benign tissue is presented in Table 1, showing a large interpatient variation in tumour uptake, tumour volume, and tumour-to-background ratio (TBR). This evidence concerns the gene FOLH1 and Familial prostate cancer.